Kolon TissueGene Inc

KRX • Healthcare • Biotechnology • Quote as of 10/30/2026

Company Profile

IndustryBiotechnology

SectorHealthcare

ExchangeKRX

Market Capitalization1,306,630 mln

Float77.82 mln

Earnings Date08/18/2025

Piotroski F-Score

3 / 9

Below average

Beneish M-Score

-4.02

Highly reliable

Relative Strength

63 / 100

Outperforming

Debt / Equity

0.31

Low leverage

Pre-Tax Margin

-3,804%

Severely loss-making

ROE

-130

Deeply negative

Key Fundamentals

EPS-2,189

ROE-130

ROIC-3.96

ROA-42.34

EBITDA, mln-176,379

EV / EBITDA-7.13

EV / EBIT-7.09

Revenue, mln4,770

EV / Revenue264

Quote Details

Last 13,920

Change -380 (-2.66%)

Open 14,430

Volume 202,995

Turnover 2,825,690,368

Average Volume 409,546

Financial Ratios

Pre-Tax Profit Margin-3,804

Current Ratio0.33

Price / Book6.36

Debt / Equity0.31

Price / Sales269

Financial Strength

Altman Z-Score-1.06

Piotroski F-Score 3 / 9

Beneish M-Score-4.02

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-9.73%	9 / 100
1 Month	-7.57%	55 / 100
2 Months	-67.55%	0 / 100
6 Months	-86.09%	0 / 100
1 Year	-69.07%	4 / 100